Compare AANJANEYA LIFECARE with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs PFIZER - Comparison Results

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS PFIZER DR. DATSONS LABS/
PFIZER
 
P/E (TTM) x -10.9 48.7 - View Chart
P/BV x 0.2 8.1 2.0% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 DR. DATSONS LABS   PFIZER
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
PFIZER
Mar-19
DR. DATSONS LABS/
PFIZER
5-Yr Chart
Click to enlarge
High Rs1263,840 3.3%   
Low Rs312,080 1.5%   
Sales per share (Unadj.) Rs133.0455.0 29.2%  
Earnings per share (Unadj.) Rs0.293.8 0.2%  
Cash flow per share (Unadj.) Rs6.6109.4 6.0%  
Dividends per share (Unadj.) Rs022.50 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs128.8658.2 19.6%  
Shares outstanding (eoy) m31.6645.75 69.2%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.66.5 9.0%   
Avg P/E ratio x516.131.6 1,635.2%  
P/CF ratio (eoy) x11.827.1 43.8%  
Price / Book Value ratio x0.64.5 13.5%  
Dividend payout %024.0 0.0%   
Avg Mkt Cap Rs m2,477135,420 1.8%   
No. of employees `000NA2.6 0.0%   
Total wages/salary Rs m563,238 1.7%   
Avg. sales/employee Rs ThNM7,911.4-  
Avg. wages/employee Rs ThNM1,230.9-  
Avg. net profit/employee Rs ThNM1,630.7-  
INCOME DATA
Net Sales Rs m4,21120,815 20.2%  
Other income Rs m791,674 4.7%   
Total revenues Rs m4,28922,489 19.1%   
Gross profit Rs m5695,712 10.0%  
Depreciation Rs m204714 28.6%   
Interest Rs m43073 590.1%   
Profit before tax Rs m136,599 0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m62,309 0.3%   
Profit after tax Rs m54,291 0.1%  
Gross profit margin %13.527.4 49.2%  
Effective tax rate %48.035.0 137.3%   
Net profit margin %0.120.6 0.6%  
BALANCE SHEET DATA
Current assets Rs m6,85227,167 25.2%   
Current liabilities Rs m6,7118,917 75.3%   
Net working cap to sales %3.387.7 3.8%  
Current ratio x1.03.0 33.5%  
Inventory Days Days16168 237.2%  
Debtors Days Days31830 1,058.0%  
Net fixed assets Rs m3,6738,862 41.4%   
Share capital Rs m317458 69.2%   
"Free" reserves Rs m3,76129,656 12.7%   
Net worth Rs m4,07830,113 13.5%   
Long term debt Rs m1,67125 6,683.2%   
Total assets Rs m12,63339,400 32.1%  
Interest coverage x1.091.5 1.1%   
Debt to equity ratio x0.40 49,357.2%  
Sales to assets ratio x0.30.5 63.1%   
Return on assets %3.411.1 31.1%  
Return on equity %0.114.2 0.8%  
Return on capital %7.722.1 34.7%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m964428 225.1%   
Fx outflow Rs m607786 77.2%   
Net fx Rs m357-358 -99.7%   
CASH FLOW
From Operations Rs m1,345978 137.5%  
From Investments Rs m-2,256351 -642.3%  
From Financial Activity Rs m-1,200-1,099 109.2%  
Net Cashflow Rs m-2,111231 -914.5%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 0.0 7.5 -  
FIIs % 1.4 4.9 27.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 23.7 397.0%  
Shareholders   20,807 85,207 24.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   FDC  FULFORD INDIA  PROCTER & GAMBLE HEALTH  AJANTA PHARMA  UNICHEM LAB  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

6 Reasons Why Sensex Plunged 883 Points Today(Closing)

Indian share markets nosedived and registered sharp losses in today's volatile session following a strong second wave of Covid-19 in the country.

Related Views on News

PFIZER Announces Quarterly Results (3QFY21); Net Profit Up 1.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, PFIZER has posted a net profit of Rs 1 bn (up 1.6% YoY). Sales on the other hand came in at Rs 6 bn (up 10.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY21); Net Profit Down 14.8% (Quarterly Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

For the quarter ended September 2020, PFIZER has posted a net profit of Rs 1 bn (down 14.8% YoY). Sales on the other hand came in at Rs 6 bn (up 5.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

Nazara Technologies IPO: Should You Apply? (IPO)

Mar 17, 2021

Should you bet on this gaming company backed by ace investor Rakesh Jhunjhunwala?

PFIZER Announces Quarterly Results (1QFY21); Net Profit Up 10.3% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, PFIZER has posted a net profit of Rs 1 bn (up 10.3% YoY). Sales on the other hand came in at Rs 5 bn (down 5.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (3QFY20); Net Profit Up 5.4% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, PFIZER has posted a net profit of Rs 1 bn (up 5.4% YoY). Sales on the other hand came in at Rs 5 bn (up 4.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits(Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS